18(c) What operating rules will you adopt to eliminate or minimize social costs?
|gTLD||Full Legal Name||Detail|
18.3 What operating rules will you adopt to eliminate or minimize social costs (e.g., time or financial resource costs, as well as various types of consumer vulnerabilities)?
The proposed operating rules limiting registration to AbbVie and its future qualified subsidiaries and affiliates will provide a trusted online environment for consumers to access AbbVie online content, and will minimize social costs by default. This verified ecosystem will also provide consumers with a single, trusted source for AbbVie’s products with a substantially lower risk of confusion than consumers encounter in .COM and other open gTLDs. Abbott does not anticipate consumer vulnerabilities; therefore, one way in which social costs will be eliminated is that trademark and brand owners will not need to defensively register second-level domains in the .ABBVIE gTLD. In fact, Abbott’s expectation is that the usage of the .ABBVIE gTLD will eliminate many of the vulnerabilities that Abbott consumers face in the wider Internet today.
18.3.1 What other steps will you take to minimize negative consequences⁄costs imposed upon consumers?
Abbott believes that the proposed operation of the .ABBVIE gTLD, as set forth in this application, has no known negative consequences or cost implications to consumers. On the contrary, the proposed operation of this registry will likely benefit consumers.
18.3.2 How will multiple applications for a particular domain name be resolved, for example, by auction or on a first-come⁄first-serve basis?
Abbott does not envision multiple applicants for the same domain name, as domain names will only be registered to AbbVie and its future qualified subsidiaries and affiliates (once identified and determined).
18.3.3 Explain any cost benefits for registrants you intend to implement (e.g., advantageous pricing, introductory discounts, bulk registration discounts).
Abbott does not envision the implementation of any advantageous pricing, introductory discounts, or bulk registration discounts because these marketing⁄commercial initiatives are inconsistent with the mission and purpose of the .ABBVIE gTLD as a trusted online source identifier. Moreover, it is intended that domain name registrations be provided to AbbVie and its future qualified subsidiaries and affiliates at no cost.
18.3.4 Note that the Registry Agreement requires that registrars be offered the option to obtain initial domain name registrations for periods of one to ten years at the discretion of the registrar, but no greater than ten years. Additionally, the Registry Agreement requires advance written notice of price increases. Do you intend to make contractual commitments to registrants regarding the magnitude of price escalation? If so, please describe your plans.
Abbott is committed to providing the domain name registration periods set forth in the Registry Agreement. However, as noted above, as a branded gTLD, the registration of the domain name is conditioned upon separate subsidiary or affiliate relationships with AbbVie. Therefore, providing contractual commitments in a domain name registrant agreement regarding the magnitude of price escalations does not seem relevant or appropriate.
Abbott acknowledges that the current template Registry Agreement requires that the Registry Operator “shall offer registrars the option to obtain registration periods for one to ten years at the discretion of the registrar.” However, AbbVie, as the sole registrant within the .ABBVIE gTLD, will only be registering domain names on an annual basis. This is done to better account for costs on an annual basis as well as to provide for more concise financial statements in Question 46, i.e., no multi-year registration or deferred revenue.
Similar gTLD applications: (4)
|gTLD||Full Legal Name||Detail|
|.GUARDIAN||The Guardian Life Insurance Company of America||View|
|.GUARDIANLIFE||The Guardian Life Insurance Company of America||View|